Innovative, collaborative solutions fully integrated into any healthcare information system
Certificates of conformity in 40 countries
170 scientific papers
and several technology patents
Our success stories
The Dimeo Imagerie Médicale group chooses Myrian applications for a collaborative work
Interview with Jean-Philippe NUEFFER, Radiologist:
"Myrian® gives satisfaction to our team on a clinical level, but above all it is an easy-to-use and adaptable tool: its functionalities are customizable and scalable. We benefited from a tailor-made support and were able to customize this tool to our practice."
Interview with Jean-Pierre MAZET, Director of IFMEM Tours
"Myrian® is the ideal solution by definition. It was absolutely fundamental to equip us with a solution that is used extensively at many sites on a routine basis and to have special options for teaching purposes. We are very pleased to keep up, so effectively, with the advances in medicine in terms of technological progress and ensure state-of-the-art training for our students."
Interview with Professor Housset
"Myrian® is a unique solution for optimizing exam reading and increasing the quality of diagnosis and therapeutic discussions; it contributes significantly to improving the quality of patient care and pathology monitoring."
Intrasense opens its share capital to the Guerbet Group, which announces its intent to file a voluntary tender offer under the same price conditions
11 January 2023
Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions ("Intrasense" or the "Company") announces that the Guerbet Group (FR0000032526 - GBT) has acquired a 39% stake in its share capital through a reserved share capital increase for a total amount of 8.8 million euros at an issuance price of 0.44 euro per share, […]
Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® (the "Group"), today announces its 2022 IFRS Group consolidated half-year financial results.
Intrasense signs a historic contract with Brazilian medical technology leader MV
11 October 2022
Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions, and MV, a key global player in the development of healthcare management software, announced the signing of a new contract to deploy the innovative solutions of the Myrian platform in Brazil, Panama, Colombia and Argentina.
Intrasense attends the 70th edition of the "Journées Francophones de Radiologie"
29 September 2022
Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian®, is pleased to announce its participation in the Journées Francophones de Radiologie (JFR). The exhibition will be held at the Palais des Congrès in Paris. The 2022 edition is dedicated to the continuity of care pathways and to "digital health". This […]
Intrasense signs a strategic partnership with Nurea
1 June 2022
Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions, and Nurea, a leading provider of decision support and diagnostic software for vascular diseases, announce the signing of a partnership that will make Nurea's artificial intelligence solution available to clinicians within theMyrian platform, through the Intrasense AI Hub.
Intrasense launches its AI Hub in partnership with Milvue
17 May 2022
Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions, announces, in partnership with the company Milvue, the first integration of a solution within its Hub dedicated to artificial intelligence. The AI Hub enables the simple and ergonomic integration of artificial intelligence algorithms and their orchestration within clinical applications to better meet theneeds of users.
Intrasense (FR0011179886 - ALINS), specialist in medical imaging softwaresolutions and designer of Myrian®, announces today the publication of its AnnualFinancial Report for the year ended December 31, 2021. This Annual FinancialReport was approved by the Board of Directors on April 19, 2022.
TeleDiag chooses Intrasense by signing a commercial contract for teleradiology
5 April 2022
Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and designer of Myrian®, and TeleDiag, a leading player in teleradiology in France entered into a partnership for the deployment of the Myrian® platform to strengthen clinical efficiency and the management of cancer patients.
Intrasense and Forcomed sign a five-year strategic partnership agreement
1 February 2022
Intrasense and Forcomed, a leading provider of continuing medical education, have entered into a five-year partnership to enable radiologists and radiology technicians to use Myrian® during a new training module on breast imagin.
Intrasense: ambitions and publication calendar for 2022
24 January 2022
Intrasense (FR0011179886 - ALINS), a specialist in medical imaging softwaresolutions and designer of Myrian®, hereby sets out its ambitions, developmentplan and financial publication timetable for 2022.
Half year report of Intrasense’s liquidity contract signed with TSAF –Tradition Securities And Futures
18 January 2022
Intrasense (FR0011179886 - ALINS), a specialist in medical imaging softwaresolutions and designer of Myrian®, announces the publication of its half yearliquidity contract signed with TSAF – Tradition Securities And Futures.
New product line in oncology: a milestone passed with the signature of a partnership between Intrasense and I-SERIS
5 October 2021
Intrasense (FR0011179886 - ALINS), a specialist in medical imaging softwaresolutions and the medical imaging and radiology group I-SERIS, which includesthe clinics of Clémentville (Montpellier), Clermont l'Hérault and the scanner centerof the Pasteur clinic in Pézenas, announce the signing of an agreement for thedevelopment of the new oncology solution Myra.
Intrasense provides an update on its development strategy and growth prospects
7 September 2021
Intrasense (FR0011179886 - ALINS), a specialist in medical imaging softwaresolutions and Myrian® designer provides an update on its development strategyfollowing its successful capital increase in June 2021.
Intrasense: successful Rights Issue with €4.9 million raised
22 June 2021
Intrasense today announced the success of its capital increase through the issuance of new shares (“New Shares”) with shareholders’ preferential subscription rights, for which subscriptions took place between May 28 and June 15, 2021 (the “Rights Issue”).
How does Myrian integrate into ris and pacs systems? How do i deploy Myrian?
Myrian can be launched from the worklist in a RIS or PACS system, with smart, direct access to the right display protocol for the type of exam that needs to be interpreted. Myrian integrates fully into your work environment, irrespective of how it’s deployed. Of course, there’s a deployment method to suit every organisation, since it’s available in standalone, application server and web-access format.
Can i customise Myrian to suit my user preferences?
You can customise the display modes yourself, according to your preferences. Our team can also help you customise your keyboard, mouse and layout shortcuts.
What support will i get once it’s installed?
Our sales team will provide personal support and answer questions you may have over time. You’ll get access to training and an on-site or remote follow-up service, day and night. Our Support engineers, based in Montpellier, are available on the phone or by email from Monday to Friday for day-to-day remote support.*
* Support disponible via l’année de garantie ou la souscription de notre contrat de service
How do i access future myrian versions and updates? How often are these released?
If you’ve signed up for a service contract, you’ll get all the latest features of Myrian when each new version is released, depending on the apps you have installed. You can also request a demo of new clinical modules. A maintenance release is available each month, and two major version releases each year.
1231 Avenue du Mondial 98, 34000 Montpellier, France